Zimbabwe has rejected a major US health deal valued at $367m (272 million pounds) over five years because of Washington's request for confidential biological samples.
The decision became public after a government memo dated December was disclosed, revealing that President Emmerson Mnangagwa deemed the agreement was "unbalanced".
A government spokesman later explained that the United States was seeking genetic material for research and profit but refused to share the benefits from future treatments.
"We must now begin the challenging and unfortunate process of ending our health aid in Zimbabwe," said American envoy to Zimbabwe Pamela Tremont in a statement.
Her embassy indicated the United States had donated over $1.9bn as health assistance to Zimbabwe during the past twenty years.
A medical body in Zimbabwe has called for continued dialogue to reach a agreement agreeable to all parties so the country's vital HIV programme can be sustained.
Wider Context
This rejection comes after a similar case in neighbouring Kenya, where a high court blocked a related health funding agreement after legal challenges were raised about the safety of Kenyans' health data.
After resuming the presidency recently, US President Donald Trump has drastically cut overseas assistance and closed the US Agency for International Development (USAID).
The agency had administered assistance for the US government, but Trump argued its spending was "wasteful" and his administration was seeking direct bilateral deals to boost openness and accountability.
According to reports, Sixteen nations in Africa have to date agreed to similar health pacts, constituting more than $18.3bn in committed funds.
Specifics of the Declined Deal
The money for Zimbabwe was intended to supported "combating HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"We believe this cooperation might have yielded significant benefits for the people of Zimbabwe, particularly the 1.2 million currently receiving HIV treatment via US-supported programmes," Tremont said.
However, official spokesman Nick Mangwana argued the proposed deal was "unequal".
"The proposal required Zimbabwe to surrender its genetic material and health information for a long time, with no equivalent guarantee of benefiting from any medical innovations – such as new medicines or tests – that could be developed from that shared data," he stated.
"Put simply, our nation would supply the basic resources for medical research with no assurance that the resulting innovations would be available to our people should a new pandemic emerge."
Sovereignty and International Frameworks
He also pointed out that the American exit from the World Health Organization (WHO) and its pursuit of bilateral deals were disrupting systems already established via the international health agency.
Mangwana cited its Pathogen Access and Benefit Sharing system created to deal with future global health emergencies.
"This system is designed to guarantee that when a nation contributes its information, the resulting advantages – including vaccines and treatments – are shared equitably, not monopolised exclusively by those with the funds to create them."
The government's concerns regarding the US deal "must not be interpreted as hostility towards the US," Mangwana stressed.
"We welcome ongoing discussions with our US partners on how subsequent collaboration might be structured in a way that respects the sovereignty and dignity of each country."
Medical Community Response
The Zimbabwe College of Public Health Physicians (ZCPHP) stated it recognised the official position, but recommended that negotiations need to persist given that much of the country's Aids initiatives relied on foreign aid.
"If specific concerns arise, such as those involving data governance or implementation frameworks, these can often be addressed through detailed discussion and mutually agreed protections," the group commented.
The situation emphasises the complex challenges between receiving crucial foreign assistance and protecting local interests in an increasingly interconnected world.